Voloridge Investment Management, LLC Vertex Pharmaceuticals Inc Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 137,088 shares of VRTX stock, worth $56 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

137,088

Previous 49,776 175.41%

Holding current value

$56 Million

Previous $23.3 Million 173.27%

% of portfolio

0.24%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $40.2 Million - $44.2 Million	87,312 Added 175.41%	137,088 $63.8 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $20.2 Million - $25 Million	-51,401 Reduced 50.8%	49,776 $23.3 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $8.08 Million - $8.84 Million	19,827 Added 24.37%	101,177 $42.3 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $16.7 Million - $20 Million	48,597 Added 148.37%	81,350 $33.1 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $6.34 Million - $6.8 Million	18,753 Added 133.95%	32,753 $11.4 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $4.4 Million - $4.93 Million	14,000 New	14,000 $4.93 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $17.4 Million - $19.6 Million	60,891 New	60,891 $17.6 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $5.11 Million - $6.36 Million	21,735 New	21,735 $6.13 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $30.9 Million - $36.4 Million	-139,353 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $70.4 Million - $88.8 Million	-397,543 Reduced 74.04%	139,353 $30.6 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $51.6 Million - $57.7 Million	284,222 Added 112.49%	536,896 $97.4 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $8.21 Million - $9.68 Million	43,799 Added 20.97%	252,674 $50.9 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $10.7 Million - $12.5 Million	-51,910 Reduced 19.91%	208,875 $44.9 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $40.4 Million - $53.9 Million	195,175 Added 297.48%	260,785 $61.6 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $16.8 Million - $19.9 Million	65,610 New	65,610 $17.9 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $19.5 Million - $24.2 Million	-97,763 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $16.3 Million - $21.9 Million	97,763 New	97,763 $21.4 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $43.6 Million - $51 Million	-287,899 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $666,906 - $755,661	-4,858 Reduced 1.66%	287,899 $43.1 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $43.4 Million - $47.5 Million	292,757	292,757 $44.5 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Vertex Pharmaceuticals Inc Transaction History